StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
637
This month
13
This week
4
This year
57
Today
1
Yesterday
4
Publishing Date
2024 - 04 - 22
3
2024 - 04 - 10
3
2023 - 11 - 27
3
2023 - 10 - 25
3
2023 - 10 - 24
3
2023 - 10 - 04
5
2023 - 10 - 03
3
2023 - 07 - 10
4
2023 - 06 - 26
4
2023 - 06 - 21
3
2023 - 06 - 13
6
2023 - 05 - 31
4
2023 - 05 - 15
3
2023 - 03 - 28
3
2023 - 03 - 23
3
2023 - 03 - 09
3
2023 - 02 - 06
3
2023 - 01 - 25
4
2022 - 11 - 10
3
2022 - 10 - 25
4
2022 - 10 - 20
4
2022 - 07 - 11
3
2022 - 06 - 21
3
2022 - 05 - 19
5
2022 - 04 - 27
3
2022 - 04 - 05
5
2022 - 02 - 28
4
2021 - 12 - 09
3
2021 - 11 - 23
3
2021 - 11 - 11
3
2021 - 11 - 10
3
2021 - 10 - 07
3
2021 - 09 - 29
3
2021 - 09 - 27
3
2021 - 09 - 13
3
2021 - 08 - 19
2
2021 - 08 - 17
2
2021 - 08 - 09
3
2021 - 07 - 27
2
2021 - 07 - 15
3
2021 - 07 - 12
3
2021 - 06 - 29
2
2021 - 06 - 28
2
2021 - 06 - 21
2
2021 - 06 - 15
2
2021 - 06 - 09
2
2021 - 06 - 07
2
2021 - 05 - 20
2
2021 - 05 - 07
2
2021 - 04 - 13
3
2021 - 04 - 12
3
2021 - 03 - 23
3
2021 - 03 - 18
3
2021 - 03 - 16
2
2021 - 03 - 15
2
2021 - 03 - 11
2
2021 - 02 - 12
2
2021 - 02 - 05
2
2020 - 12 - 15
2
2020 - 12 - 10
4
Sector
Administrative and support and waste management and remediation services
2
Commercial services
4
Communications
11
Consumer durables
1
Consumer non-durables
4
Consumer services
2
Distribution services
1
Electronic technology
17
Energy minerals
3
Finance
13
Finance and insurance
1
Health care and social assistance
1
Health services
5
Health technology
390
Industrial services
9
Information
3
Manufacturing
41
Mining, quarrying, and oil and gas extraction
4
Miscellaneous
1
N/a
28
Non-energy minerals
10
Process industries
9
Producer manufacturing
12
Professional, scientific, and technical services
25
Real estate and rental and leasing
1
Retail trade
3
Technology services
21
Transportation
1
Transportation and warehousing
1
Utilities
10
Tags
Acquisition
738
Agreement
920
America
659
Application
1355
Approval
1352
Business
630
Cancer
1848
Collaboration
685
Conference
2337
Contract
837
Corporation
840
Covid
767
Covid-19
581
Designation
908
Disease
1192
Drug
1440
Energy
1435
Europe
739
Events
561
Fda
2717
Financial
2057
Financial results
964
For
824
Global
1753
Group
655
Growing
628
Growth
2831
Health
891
License
672
Management
604
Market
3388
Meeting
994
N/a
46154
Order
630
Partnership
554
Patent
816
Pharm-country
600
Pharmaceuticals
666
Phase 2
720
Platform
659
Positive
1230
Potential
637
Presentation
600
Program
757
Report
1754
Research
2561
Results
4616
Services
665
Solutions
713
Study
848
System
776
Technology
1172
Test
716
Therapeutics
1802
Therapy
1318
Treatment
3938
Trial
2270
Update
646
Vaccine
597
Year
1860
Entities
3m company
3
Abbott laboratories
2
Abbvie inc.
6
Adamis pharmaceuticals corporation
4
Adial pharmaceuticals, inc
7
Aeterna zentaris inc.
5
Akari therapeutics plc
5
Alnylam pharmaceuticals, inc.
4
Amgen inc.
3
Arcutis biotherapeutics, inc.
8
Baxter international inc.
4
Biogen inc.
8
Biomea fusion inc
4
Bioxcel therapeutics, inc.
4
Bridgebio pharma, inc.
7
Cns pharmaceuticals, inc.
6
Cognition therapeutics inc
3
Corvus pharmaceuticals, inc.
4
Dare bioscience, inc.
5
Denali therapeutics inc.
6
Duke energy corporation
7
Eli lilly and company
8
Enochian biosciences, inc.
10
Ericsson
3
Galecto, inc.
3
Humanigen, inc.
4
Ideaya biosciences, inc.
5
In8bio inc
3
Inozyme pharma, inc.
3
Jaguar health, inc.
3
Johnson & johnson
15
Lithium corp
3
Lumos pharma, inc.
3
Magellan midstream partners l.p.
6
Nanobiotix - adr
3
Novartis ag
3
Novocure limited
4
Nuvalent inc - class a
3
Orange
9
Panbela therapeutics inc
3
Pfizer, inc.
6
Phathom pharmaceuticals, inc.
4
Precision biosciences, inc.
3
Reata pharmaceuticals, inc.
9
Recursion pharmaceuticals inc - class a
3
Regeneron pharmaceuticals, inc.
3
Relmada therapeutics, inc.
4
Renovorx inc
4
Sab biotherapeutics inc
3
Sanofi
23
Scynexis, inc.
3
Sea limited
3
Sutro biopharma, inc.
3
Theravance biopharma, inc.
4
Tonix pharmaceuticals holding corp.
12
Verrica pharmaceuticals inc.
3
Verve therapeutics inc
3
Viatris inc.
3
Vir biotechnology, inc.
4
Zai lab limited
3
Symbols
ABBV
6
ADIL
7
ADMP
4
AEZS
5
AKTX
5
ALNY
4
AMGN
3
ARQT
8
BAX
4
BBIO
7
BIIB
8
BMEA
4
BTAI
4
CGTX
3
CNSP
6
CRVS
4
DARE
5
DNLI
6
DTIL
3
DUK
7
ENOB
10
ERIC
3
FNCTF
9
GLTO
3
HGEN
4
IDYA
5
INAB
3
INZY
3
JAGX
3
JNJ
15
LLY
8
LTUM
3
LUMO
3
MMM
3
MMP
6
NBTX
3
NUVL
3
NVCR
4
NVS
3
PBLA
3
PFE
6
PHAT
4
REGN
3
RETA
9
RLMD
4
RNXT
4
RXRX
3
SABS
3
SCYX
3
SE
3
SNY
23
SNYNF
21
STRO
3
TBPH
4
TNXP
12
VERV
3
VIR
4
VRCA
3
VTRS
3
ZLAB
3
Exchanges
Amex
13
Nasdaq
539
Nyse
126
Crawled Date
2024 - 04 - 22
3
2024 - 04 - 10
3
2023 - 12 - 12
3
2023 - 11 - 27
3
2023 - 10 - 25
3
2023 - 10 - 24
3
2023 - 10 - 04
5
2023 - 10 - 03
3
2023 - 07 - 10
4
2023 - 06 - 26
4
2023 - 06 - 21
3
2023 - 06 - 13
6
2023 - 05 - 31
4
2023 - 05 - 15
3
2023 - 03 - 28
3
2023 - 03 - 09
3
2023 - 02 - 06
3
2023 - 01 - 25
4
2022 - 11 - 10
3
2022 - 10 - 25
4
2022 - 10 - 20
4
2022 - 07 - 11
3
2022 - 06 - 21
3
2022 - 05 - 19
5
2022 - 04 - 27
3
2022 - 04 - 05
5
2022 - 02 - 28
4
2021 - 12 - 09
3
2021 - 11 - 23
3
2021 - 11 - 11
3
2021 - 11 - 10
4
2021 - 10 - 07
3
2021 - 09 - 29
3
2021 - 09 - 27
3
2021 - 09 - 13
3
2021 - 08 - 09
3
2021 - 07 - 15
3
2021 - 07 - 13
2
2021 - 07 - 12
2
2021 - 06 - 29
2
2021 - 06 - 28
2
2021 - 06 - 21
2
2021 - 06 - 15
2
2021 - 06 - 09
2
2021 - 06 - 07
2
2021 - 05 - 20
2
2021 - 05 - 07
2
2021 - 04 - 13
3
2021 - 04 - 12
3
2021 - 03 - 23
3
2021 - 03 - 18
3
2021 - 03 - 16
2
2021 - 03 - 15
2
2021 - 03 - 11
2
2021 - 02 - 12
2
2021 - 02 - 05
2
2021 - 01 - 21
2
2020 - 12 - 15
3
2020 - 12 - 11
2
2020 - 12 - 10
3
Crawled Time
00:00
5
00:01
2
01:00
10
02:00
1
03:00
3
04:00
4
04:20
1
05:00
5
06:00
7
07:00
7
08:00
5
09:00
14
09:07
1
10:00
15
10:16
1
11:00
33
12:00
92
12:01
1
12:03
2
12:11
1
12:15
5
12:20
21
12:26
1
12:27
1
12:30
20
13:00
58
13:15
8
13:20
20
13:30
17
13:32
1
13:33
1
13:59
1
14:00
42
14:01
2
14:02
2
14:03
2
14:11
1
14:12
1
14:15
3
14:20
5
14:30
10
14:47
1
15:00
30
15:08
1
15:15
1
15:20
6
15:30
3
16:00
20
16:20
7
17:00
9
17:10
1
18:00
19
18:01
1
19:00
17
19:02
1
20:00
16
20:20
5
21:00
26
22:00
18
23:00
21
Source
brainsway.com
1
ir.biolinerx.com
1
ir.pulmatrix.com
1
ir.vaccinex.com
1
ir.vtvtherapeutics.com
1
jaguarhealth.gcs-web.com
3
neurosense.investorroom.com
1
renovorx.com
3
spacfeed.com
10
www.affimed.com
1
www.allogene.com
1
www.amcnetworks.com
2
www.americanlithiumcorp.com
1
www.bactechgreen.com
1
www.biospace.com
230
www.blackknightinc.com
1
www.catalent.com
1
www.concentrix.com
1
www.confluent.io
1
www.enochianbio.com
5
www.fda.gov
1
www.fpxnickel.com
2
www.globenewswire.com
231
www.goldreserveinc.com
1
www.igcinc.us
1
www.kopin.com
1
www.precisionbiosciences.com
1
www.prnewswire.com
129
www.quantumcomputinginc.com
1
www.veritone.com
1
www.vynetherapeutics.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
for
tags :
Potential
save search
Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
Published:
2024-04-23
(Crawled : 12:00)
- globenewswire.com
HOWL
|
$6.41
5.26%
4.99%
390K
|
Professional, Scientific, and T...
|
1.5%
|
O:
3.92%
H:
0.0%
C:
0.0%
il-10
first
disease
preclinical
for
meeting
therapeutics
potential
therapy
Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting
Published:
2024-04-22
(Crawled : 20:00)
- globenewswire.com
TOVX
|
News
|
$0.3769
-8.3%
-1.83%
1.2M
|
Manufacturing
|
0.0%
|
O:
0.73%
H:
0.0%
C:
0.0%
vcn-01
cancer
pancreatic
cell
preclinical
for
meeting
potential
therapy
Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
Published:
2024-04-22
(Crawled : 14:00)
- biospace.com/
ENDPQ
|
News
|
$0.0007
-50.0%
1K
|
n/a
|
Email alert
Add to watchlist
ENDP
|
News
|
$0.2926
-9.6%
|
Health Technology
|
Email alert
Add to watchlist
solution
for
nationwide
potential
injection
BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its Market Potential
Published:
2024-04-22
(Crawled : 11:00)
- globenewswire.com
BTAI
|
News
|
$2.965
4.04%
3.88%
410K
|
Health Technology
|
9.83%
|
O:
5.2%
H:
4.76%
C:
4.4%
bxcl501
for
therapeutics
potential
market
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Verve Therapeutics, Inc. for potential violations of federal securities laws
Published:
2024-04-19
(Crawled : 15:00)
- prnewswire.com
VERV
|
$6.88
-0.43%
-0.44%
960K
|
Professional, Scientific, and T...
|
2.52%
|
O:
-2.23%
H:
3.19%
C:
0.76%
for
potential
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
Published:
2024-04-17
(Crawled : 05:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.63%
|
O:
0.12%
H:
0.51%
C:
0.51%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.88%
|
O:
1.05%
H:
0.0%
C:
0.0%
sclerosis
for
potential
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
Published:
2024-04-10
(Crawled : 12:30)
- globenewswire.com
ADIL
|
News
|
$1.73
-8.95%
-9.83%
440K
|
Health Technology
|
65.22%
|
O:
123.48%
H:
0.0%
C:
0.0%
ad04
alcohol
publication
treatment
pharmaceuticals
for
trial
potential
Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy on May 23, 2024
Published:
2024-04-10
(Crawled : 11:00)
- biospace.com/
TBPH
|
$9.21
-2.64%
-2.71%
340K
|
Health Technology
|
-0.21%
|
O:
-1.37%
H:
2.14%
C:
2.03%
treatment
system
for
key
potential
Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024
Published:
2024-04-10
(Crawled : 10:00)
- prnewswire.com
TBPH
|
$9.21
-2.64%
-2.71%
340K
|
Health Technology
|
-0.21%
|
O:
-1.37%
H:
2.14%
C:
2.03%
treatment
system
for
key
potential
Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”
Published:
2024-04-09
(Crawled : 12:30)
- globenewswire.com
TENX
|
$3.59
0.84%
0.84%
12K
|
Health Technology
|
-6.32%
|
O:
7.89%
H:
1.95%
C:
-2.93%
first
levosimendan
treatment
ongoing
for
therapeutics
potential
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections
Published:
2024-04-04
(Crawled : 12:30)
- biospace.com/
SNOA
|
$0.1574
4.76%
150K
|
Health Technology
|
1.27%
|
O:
-6.39%
H:
10.21%
C:
8.18%
australia
publication
pharmaceuticals
infections
potential
Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer
Published:
2024-04-01
(Crawled : 13:00)
- globenewswire.com
CYCC
|
$1.805
3.14%
3.05%
28K
|
Health Technology
|
-17.06%
|
O:
4.27%
H:
0.0%
C:
-5.45%
precision
asco
cancer
pharmaceuticals
meeting
potential
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
Published:
2024-04-01
(Crawled : 10:00)
- globenewswire.com
LQDA
S
|
$12.96
-1.67%
-1.7%
1.2M
|
Health Technology
|
-12.43%
|
O:
2.99%
H:
0.06%
C:
-3.74%
fda
approval
favorable
update
potential
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
Published:
2024-03-28
(Crawled : 13:30)
- globenewswire.com
FBLG
|
$11.07
2.41%
2.35%
48K
|
|
-8.0%
|
O:
-1.87%
H:
0.0%
C:
-6.24%
patent
lupus
treatment
application
technology
potential
COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: Glo...
Published:
2024-03-27
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.26%
|
O:
-0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-5.95%
|
O:
1.06%
H:
0.0%
C:
0.0%
copd
potential
market
COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: GlobalData
Published:
2024-03-27
(Crawled : 12:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.26%
|
O:
-0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-5.95%
|
O:
1.06%
H:
0.0%
C:
0.0%
copd
potential
market
FDA Approves Potential 'Game Changer' for Pulmonary Arterial Hypertension
Published:
2024-03-26
(Crawled : 23:00)
- biospace.com/
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-4.18%
|
O:
0.01%
H:
0.0%
C:
0.0%
fda
hypertension
potential
Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet Syndrome
Published:
2024-03-25
(Crawled : 23:00)
- biospace.com/
STOK
|
$11.24
-0.09%
-0.09%
600K
|
Health Technology
|
78.57%
|
O:
-0.16%
H:
8.11%
C:
3.34%
stk-001
first
treatment
therapeutics
potential
DraftKings and Kindbridge Behavioral Health Expand Program That Provides Treatment Resources for Individuals Experiencing Potential Indications of Problem Gaming
Published:
2024-03-21
(Crawled : 20:00)
- globenewswire.com
DKNG
|
News
|
$41.2
1.6%
1.58%
7.1M
|
Technology Services
|
-15.43%
|
O:
-0.5%
H:
1.82%
C:
-1.07%
health
treatment
program
gaming
potential
Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia
Published:
2024-03-13
(Crawled : 13:30)
- biospace.com/
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-7.03%
|
O:
0.21%
H:
0.17%
C:
0.14%
tak-079
positive
topline
potential
results
study
← Previous
1
2
3
4
5
6
7
8
9
…
31
32
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.